Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
What are the 6 Hallmarks of Cancer?
|
1. Loss of GF-dependence
2. lack of responsiveness to anti-growth signals 3. resistance to apoptosis 4. limitless replicative potential 5. recruitment of blood and lymph (angiogenesis) 6. invasion and metastasis |
|
What are the 3 major phases of cancer development?
|
metaplasia --> dysplasia --> anaplasia
|
|
What are carcinomas derived from?
Give an example. |
epithelial origin. Ex: lung, colon, breat, and prostate cancers
|
|
What are sarcomas derived from?
Give an example. |
mesenchymal and connective tissues.
Ex: bone and muscle cancers |
|
What are leukemias/lymphomas derived from?
Give an example. |
white blood cell tumors
|
|
What are germinal tumors derived from?
Give an example. |
germ cell cancers
|
|
What is a proto-oncogene?
Give examples. |
= a normal cellular gene that, upon alteration of DNA-damaging agents or viral genomes, can acquire the ability to function as an oncogene.
ex: c-src, Ras G12, c-myc |
|
What is an oncogene?
Give examples. |
= a gene that can transform cells.
ex: v-src, Ras G12V or G12D, v-myc, overexpressed MDM2 and AKT |
|
What is a tumor suppressor gene?
Give examples. |
= a gene whose partial or complete inactivation leads to an increased likelihood of cancer development; this gene is responsible for constraining cell proliferation.
ex: pRb, p53, p19ARF, PTEN |
|
What is the structure of c-src? What is its main task?
|
- 533 AAs long, phosphorylated on Y527 inhibiting phosphorylation of Y416; regulated kinase activity
- required for normal growth and development. |
|
How can you activate c-src?
|
1) remove phophoryl group on Y527 and add one on Y416
2) SH2 ligand binding (binds phophorylated tyrosines) 3) SH3 ligand binding (binds polyPro stretches) |
|
What downstream signaling pathways of Src lead to Motility?
|
activation of substrates at focal adhesion
|
|
What downstream signaling pathways of Src lead to Proliferation and Survival?
|
1) Activation of docking proteins --> PI3K --> (PDK1) --> AKT --> mTor --| BD and --> translation and metabolism
2) Adaptors (GEFs) --> Ras --> Raf --> MEK --> MAPK --> translation and metabolism 3) Activation of Tyr kinases --> Stat3 --> Myc and Cyclin D1 |
|
What downstream signaling pathways of Src lead to Cell-cell adhesion?
|
1) Activation of Tyr kinases --> Stat3 --> Myc and Cyclin D1
2) activation of substrates at cell-cell contacts |
|
What is the structure and function of v-myc?
|
- 526 AA long, autophosphorylates at Y416 and is thus constituitively active kinase --> dysregulated cell division, survival, and motility
- gives normal cells transforming ability |
|
How is oncogenic v-src activated?
|
1) deletion in c-myc --> gain of function mutation
2) many point mutations (especially in SH3 domain) |
|
What is the normal function and structure of Ras?
|
- its a GTPase that is active when bound by GTP (encouraged by GEF) and inactive when bound by GDP (due to GAP)
- mediates GF signaling |
|
What is the upstream signaling pathway of Ras?
|
GF binds --> RTKS dimerize and autophosphorylate --> GRB2 binds RTKs via SH2 --> SOS recruited to PM and GRB2 binds it via SH3 domains --> SOS (a GEF) activates Ras --> Sos dissociates
|
|
What is the downstream signaling pathway of Ras?
|
Raf goes to the PM --> Raf hydrolyzed and activated by Ras --> Raf binds and phosphorylates MEK --> MEK phosphorylates and activates MAPK --> MAPK dimerizes and translocates to the nucleus --> phosphorylation of TFs that promote cell growth
|
|
What are the 4 downstrean effectors of the Ras pathway? What are the major functions of each?
|
1. Raf-MAPK: transcription, cell cycle progression
2. PI3K- Rac: survival, transcription, translation, cytoskeleton 3. RalGDS: cell cycle progression, transcription, vesicle transport 4. PLC-epsilon: Calcium signaling |
|
What 3 things contribute to the diversity of this major Ras pathway?
|
1. 4 different EGF receptor subunits
2. 3 Ras forms (K-, H-, N-) 3. 3 MAPK forms (ERK, JNK, JAPK) |
|
What is the signaling pathway that connects Ras and p53?
|
Ras, Myc --> E2F --> ARF --| MDM2 --| p53 --> apoptosis or arrest
|
|
How is the oncogenic form of Ras formed?
|
from a point mutation: --> RasG12V or Ras G12D
|
|
What are the 3 Major forms of Ras? What cancers are they associated with
|
1. K-Ras: pancreatic, lung, and colon cancers
2. H-Ras: bladder and urinary tract cancers 3. N-Ras: leukemias |
|
What are the 5 Ras pathway components implemented in Cancers?
|
Ras, RTKs, Raf, GAPs, Ligand Overexpression
|
|
How is Ras implicated in cancer?
|
- locked in a perpetually active state
- mutation destroys GTPase activity |
|
How are RTKs implicated in cancer?
|
- overexpression of Her2-neu leads to increased signaling (involved in breast cancers)
- N-terminus truncation --> constituitive Y-kinase activity (signals without ligand) |
|
How is Raf implicated in cancer?
|
- overexpression associated with lung and liver tumors
- mutations in B-Raf --> melanomas and colon because it's constituitively on |
|
How are GAPs implicated in cancer?
|
- the major one involved: neurofibromin, which is deficient in patients with neurofibrosarcomas, leukemias, etc
|
|
How is ligand overexpression implicated in cancer?
|
- results in constituitive signaling
|
|
What is the normal function of c-myc?
|
it is a bHLH-LZ TF that binds DNA with MAX
|
|
How does MAX act?
|
activating: MYC::MAX (SKP2, HAT::TRRAP)
repressing: MNT::MAX and MAD::MAX (HDAC::SIN3) |
|
What are the upregulation and downregulation pathways that involve Myc?
|
upregulation: MYC::MAX bind E boxes --> rtanscription (boxes normally inhibited by MAD::MAX and MNT::MAX)
downregulation: MYC::MAX binds and represses MIZ1 (usually transcribes INR, thus encouraging cell cycle progression) |
|
What happens to a loss of myc in developing organisms?
|
Smaller organisms
|
|
In what 3 ways does Myc drive cell cycle progression?
|
1. drives CyclinD-CDK4/6 expression --> phosphorylation of pRb
2. by inhibiting MIZ1, it decreased p15INK4b, p21, and p27 expression 3. increases expression of E2f1-3 proteins in late G1 |
|
What is the pathway that links p53 and myc?
|
Myc, Ras --> E2F --> ARF --| MDM2 --| p53 --> apoptosis or arrest
|
|
By what a3 methods does myc become oncogenic?
|
1) gene amplification: (N- and L- myc) N-myc in childhood neuroblastomas
2) viral insertion before promoter: v-myc 3) chromosome translocation: (c-myc) in Burkitt's Lymphoma - B-cell tumor caused by reciprocal translocation between c-myc and IgG locus, resulting in myc before a very strong promoter |
|
What does increasing [MYC] do?
|
- increases the number of MYC::MA complexes, thus increasing transcription
- increased upregulation and increased downregulation --> tumorigenesis (includes transformation/angiogenesis, apoptosis, cell-cycle progression, blocks cell differentiation, genomic instability, reduced dependence on GFs, and increased cell size) |
|
What 5 features does Myc affect to lead to tumorigenesis?
|
cell-cycle, growth, deaht/immortality, adhesion matrix, and genomic instability
|
|
How does Myc affect cell-cycle and lead to tumorigenesis?
|
increases cdc25A, CDK4, and cyclin D2, while decreasing CDKI, p21, and p 27
|
|
How does Myc affect growth and lead to tumorigenesis?
|
increases eIF4E and decreases H-ferritin = larger cells
|
|
How does Myc affect death/immortality and lead to tumorigenesis?
|
death: increases p53 and ARF
immortality: increases hTERT |
|
How does Myc affect adhesion matrix and lead to tumorigenesis?
|
decreases collagen fibronectin (no dependence)
|
|
What is the normal function of pRb?
|
It is integral to cell cycle progression.
|
|
List the normal functioning pathway of pRb in cell cycle progession.
|
pRb represses E2Fs --> GF binds receptors --> cyclin D expression --> cyclinD-CDK4/6 begin phosphorylating pRb --> pRb begins to release E2Fs --> pRb hyperphosphorylated and pushed through RP --> after this point pRb hyperphosphorylation is maintained through M and GFs have no influence anymore --> phosphatases come in at the end of M --> pRb phosphorylated and repressing E2Fs
|
|
Who are the members of the "pocket" protein family? What are their concentrations throughout the cell cycle?
|
- all members can alter cell cycle progression when overexpressed
- pRb = p105, concentration is constant throughout - p107 is induced - p130 decreases |
|
What signaling pathway connects pRb to p53?
|
Myc, Ras --> D-CDK4/6 and E-CDK2 -| Rb-E2F --> E2F --> RP --> p19ARF --| mdm2 --| p53 --> p21 (and p16INK4a) --| D-CDK4/6 and E-CDK2
|
|
What is retinoblasotma? What two forms is it observed in?
|
= causes retinal tumors caused by loss of function mutations in Rb
- if inherited, bilateral tumors appearing autosomal dominant due to LOH - if acquired via 2 somatic mutations, then unilateral tumors |
|
How are cells immortalized by viral oncogenes interacting with pRb?
|
Viral oncogenes bind B-boxes --> induces conformational change --> change induced in "pocket" --> disturbed Rb form
- ex: SV40, HPV E7 protein, adenovirus E1A |
|
How does loss of function in pRb affect cell cycle?
|
It accelerates progression, as there are increased free E2F levels
|
|
What inhibits CyclinD-CDK4/6 molecules?
|
INK4 family of proteins: p16INK4a, p15INK4b, p18INK4c, p19INK4d
|
|
What molecules inhibit Cyclin-CDK complexes from late G1 --> M?
|
p21Cip1, p27Kip1, p57Kip2
|
|
What does E2F release activate? What does it repress?
|
activates p19ARF
represses p27 via phosphorylation --> ubiquitylation --> degradation in the proteasome |
|
What are the positive factors in cell-cycle progression? What does the overexpression of these lead to?
|
- Cyclin D1-D3, CDK4/6, Cyclin E
- overexpression leads to a shortened G1 |
|
Which cell-cycle inhibitor is most often silenced in cancers?
|
p16INK4a is often lost/silenced through Methylation in cancer cells
|
|
What is the ATM pathway? When does it occur? What is it activated by?
|
ATM activated Chk2 (--> p53), p53, and mdm2 via phosphorylation : all serve to stabilize p53 --> p21 expression --| E-CDK2 --> arrest
Activated by IR when DNA damage occurs before S. |
|
How is Li-Fraumeni Syndrome acquired?
|
the inactivation of 1 allele of p53 gene leads to inactivation of 15/16 of p53 tetramer complexes in the cell.
This acts a dominant negative mutation, and patients have an increased likelihood of developing a multitude of cancers |
|
In addition to p53 loss of function, what other molecular compound needs be inactivated in order to develop cancer? Why is this?
|
pRb, because loss of function of just one would lead merely to cell cycle arrest.
|
|
How do malignant cells eliminate the p53 pathway?
|
- pt mutation of p53
- deletion of ARF - overexpression of MDM2 - p53 localized to the cytoplasm |
|
How do malignant cells inactivate apoptosis?
|
- inactivate Apaf-1 promoter
- Bax gene mutation - increase Bcl2 expression - inactivate caspase 8 |
|
What is FLIP?
|
in cancer, this is a molecular structure similar to procaspase 8, which lacks its cleave site, but docks with Fas and blocks procaspase 8
|
|
What is NF-kB?
|
expressed in cancer cells via death receptor singaling; it is a TF that protects from apoptosis and is associated with differentiation
|
|
How do cytotoxic T cells or NKs contribute to apoptosis?
|
Tc or NK binds --> releases granzyme B --> activates executioner (casp. 3) --> cascade and Bid
|
|
What are the anit-apoptotic proteins?
|
Blc2, Bcl-X, Bcl-w
|
|
What are the pro-apoptotic proteins?
|
Bax, Bak, and Bim and Bid
|
|
What are the two subunits of Telomerase? What are their functions?
|
TERC and TERT. TERC is the RNA template and TERT contains the reverse transcriptase catalytic subunit
|
|
What is the Hayflick limit?
|
= cells undergo predictable number of doublings before senescence
this can be suppressed by TERT activation |
|
What are some qualities of senescent cells?
|
increased p53, p19ARF, and p16INK4a levels
hypophosphorylated pRb morphological changes, express SA-beta-Gal, bigger and flatter |
|
What happens if you inhibit Trf2? How does this relate to cancer?
|
all chromosomes become linked and enter crisis. the cell interprets this as DNA damage. This formation is accomplished by BFB cycles, resulting in amplifications, deletions, and introduction of large amounts of damage --> new mutations
|